Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

10,506articles mentioning drugs

58,393drug mentions

9,496distinct drugs extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

View all 9,496 drugs on one page

Articles mentioning drugs

10,506 articles · page 93 of 876

45 Implementing the aortic dissection detection risk score (ADD-RS) and D-dimer for risk stratifying patient with suspected acute aortic dissection in a district general hospital

heartjnl · abstract · 2026-06-09 · 11 matching annotations

97.0%

D-Dimer Angina acute aortic dissection European Society of Cardiology Acute aortic syndromes (AASs)diverticulitis

…o the European Society of Cardiology ADD-RS in combination with D-Dimer for investigating patients with suspected AAD.Methods We perfor…

Comparing bridging drug therapy approaches prior to balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: a prospective analysis from the national UK CURATE registry

openhrt · abstract · 2026-06-08 · 11 matching annotations

94.7%

PDE5i riociguat ERA endothelin receptor antagonist Royal Papworth Hospital CTEPH chronic thromboembolic PH (CTEPH)Pulmonary hypertension BPA

…triuretic peptide (−67% vs −21% vs −32%, p=0.004) compared with PDE5i monotherapy and riociguat monotherapy. These differences persis…

OC.53 Use of the CD19/CD3 T cell engager blinatumomab in refractory systemic sclerosis: a case series

jsrd · abstract · 2026-06-05 · 11 matching annotations

97.7%

hydrocortisone blinatumomab acetaminophen dexchlorpheniramine tocilizumab systemic sclerosis interstitial lung disease pulmonary hypertension

…ry review to validate its off-label use. The treatment included hydrocortisone (100 mg), acetaminophen (1 g), and dexchlorpheniramine (5 mg), …

P.026 Treprostinil, a prostacyclin analog, mitigates profibrotic signaling in scleroderma fibroblasts via the EP2–PPARG–SMARCA4 pathway

jsrd · abstract · 2026-06-05 · 11 matching annotations

99.2%

Treprostinil RO1138452 GW9662 systemic sclerosis SSc

…Bs demonstrate impaired prostacyclin–IP antifibrotic signaling. Treprostinil exerts its antifibrotic effects primarily through EP2 activatio…

P.120 Outcomes of upfront combination vs monotherapy with rituximab or mycophenolate mofetil for systemic sclerosis interstitial lung disease (SSc-ILD): results from an EUSTAR cohort study

jsrd · abstract · 2026-06-05 · 11 matching annotations

96.6%

mycophenolate mofetil tocilizumab rituximab nintedanib MMF RTX Interstitial lung disease (ILD)systemic sclerosis (SSc)EUSTAR SSc-ILD

… (SSc) patients. The recent ERS/EULAR guidelines recommend both mycophenolate mofetil (MMF) and rituximab (RTX) for SSc-ILD and suggest to use a comb…

P.128 Real-life effectiveness of Selexipag treatment in systemic sclerosis associated pulmonary arterial hypertension: long-term data from a multicentric Italian cohort

jsrd · abstract · 2026-06-05 · 11 matching annotations

98.8%

Selexipag Pulmonary arterial hypertension (PAH)Systemic sclerosis (SSc)SSc-PAH

…arting Selexipag within 2 years from PAH diagnosis. Reasons for Selexipag discontinuation included 5 (11.4%) adverse drug reactions (ADR)…

P.130 Immunosuppressive therapy and risk of incident pulmonary arterial hypertension in systemic sclerosis: results from the Canadian Scleroderma research group

jsrd · abstract · 2026-06-05 · 11 matching annotations

99.6%

mycophenolate mofetil methotrexate tocilizumab azathioprine tacrolimus leflunomide cyclophosphamide rituximab systemic sclerosis (SSc)vasodilator therapy+3 more

…urgitation. Exposure to immunosuppressive agents (methotrexate, mycophenolate mofetil, azathioprine, cyclophosphamide, tacrolimus, leflunomide, ritux…

Spinal anesthesia with mepivacaine versus bupivacaine: early start, same finish—an infographic

rapm · abstract · 2026-06-05 · 11 matching annotations

97.1%

bupivacaine Spinal mepivacaine mepivacaine hip arthroplasty urinary retention

…tistically faster return of motor function compared with spinal bupivacaine (median 210 min vs 229 min, respectively, p<0.001), but this di…

Patient and family experiences of sedation in an urban academic tertiary-level intensive care unit in Canada: a qualitative study

bmjopen · abstract · 2026-05-19 · 11 matching annotations

89.7%

sedation delirium sedation

…medical procedures in the ICU, both groups reported concerns of sedation use, including negative physiological and cognitive patient out…

Intracranial Dotter angioplasty using Tenzing (Tenzingplasty) for acute ischemic stroke with underlying intracranial atherosclerotic disease

neurintsurg · abstract · 2026-05-14 · 11 matching annotations

96.2%

Tenzing Tenzingplasty-related Dotter Tenzingplasty ICAD Route 92 Medical

…diameter of 1.2 mm (Tenzing 5), 1.6 mm (Tenzing 7), and 2.1 mm (Tenzing 8).Objective To report our initial experience treating acutely …

Incidence of transient neurologic symptoms in patients receiving lidocaine spinal anesthesia for outpatient joint arthroplasty

rapm · abstract · 2026-05-05 · 11 matching annotations

98.2%

lidocaine bupivacaine dexamethasone acetaminophen non-steroidal anti-inflammatory drug intravenous ketamine TNS

…ck associated with bupivacaine can delay recovery. In contrast, lidocaine, with its swift onset and intermediate duration, is an attracti…

Subpectoral plexus block to enhance surgical anesthesia produced by a multilevel thoracic paravertebral block for primary breast cancer surgery: a prospective randomized double-blind study

rapm · abstract · 2026-05-05 · 11 matching annotations

98.4%

Ketamine dexmedetomidine Midazolam Gp-A 6m-TPVB Gp-B Numeric Rating Scale PBCS breast cancer

…ery commenced about 25–30 min after the completion of the SPPB. Ketamine (10–20 mg IV bolus) was used for rescue analgesia (our primary …